Publications by authors named "Alicia Cuenca-Zarzuela"
Stage IV mixed adenoneuroendocrine carcinoma of sigmoid colon in complete response after immunotherapy. Closer to curing neuroendocrine neoplasms?
Gastroenterol Hepatol
March 2024
We present the case of a 38-year-old woman who, in the context of a 22-week gestation, was diagnosed with diffuse gastric adenocarcinoma. The age of the patient and the way in which the cancer presented itself, make genetic counseling mandatory to rule out hereditary diffuse gastric carcinoma syndrome. This rare entity, of autosomal dominant inheritance and closely linked to mutations in the CDH1 (in most cases) and CTNNA1 genes, is associated with a greater predisposition to develop malignant neoplasms of the breast and stomach.
View Article and Find Full Text PDFWe bring forward a case of a 58-year-old female who, undergoing treatment for glioblastoma with temozolomide and radiotherapy, visited the Emergency Department due to acute abdominal pain and chemotherapy-induced febrile neutropenia. She was diagnosed with sepsis due to phlegmonous gastritis. After several weeks in the Intensive Care Unit with antimicrobial coverage, our patient was discharged.
View Article and Find Full Text PDFArticle Synopsis
- The text introduces a new algorithm designed to detect cancer at an early stage.
- This algorithm is specifically aimed at identifying cancer linked to paraneoplastic syndrome, a condition caused by cancer that affects other parts of the body.
- The proposed method could potentially improve cancer diagnosis and treatment by recognizing symptoms associated with this syndrome.
Article Synopsis
- A 65-year-old woman was diagnosed with chronic intestinal pseudo-obstruction (CIPO) related to small cell lung carcinoma (SCLC) after experiencing dyspepsia and bowel dismotility.
- She had a significant response to treatment, which included both chemotherapy and immunotherapy.
- Unfortunately, she succumbed to intestinal sepsis, resulting in her unexpected death despite the positive response to cancer treatment.
Aims: The association of on-admission CRP and early adverse outcomes in acute venous thromboembolism (VTE) has not been investigated. We hypothesized that increased on-admission CRP levels would correlate with adverse outcomes in patients with acute VTE.
Method: In this prospective observational study, consecutive patients with acute VTE were enrolled and CRP levels were measured within the first 24h after diagnosis.